ベルギー - オランダ語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - leflunomide 20 mg - filmomhulde tablet - leflunomide

ベルギー - オランダ語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - leflunomide 20 mg - filmomhulde tablet - leflunomide

ベルギー - オランダ語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - leflunomide 20 mg - filmomhulde tablet - leflunomide

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (ra). leflunomide is contraindicated in: - pregnant women. leflunomide may cause fetal harm. if a woman becomes pregnant while taking this drug, stop leflunomide, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [see warnings and precautions (5.1 and 5.3) and use in specific populations (8.1)]. - patients with severe hepatic impairment [see warnings and precautions (5.2)]. - patients with known hypersensitivity to leflunomide or any of the other components of leflunomide tablets. known reactions include anaphylaxis [see adverse reactions (6.1)]. - patients being treated with teriflunomide [see drug interactions (7)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to leflunomide during pregnancy. health care providers and patients are encouraged to report pregnancies by calling 1-877-311-8972 or visit

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

zydus lifesciences limited - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (ra). leflunomide is contraindicated in: - pregnant women. leflunomide may cause fetal harm. if a woman becomes pregnant while taking this drug, stop leflunomide, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [see warnings and precautions (5.1 and 5.3) and use in specific populations (8.1)]. - patients with severe hepatic impairment [see warnings and precautions (5.2)]. - patients with known hypersensitivity to leflunomide or any of the other components of leflunomide tablets. known reactions include anaphylaxis [see adverse reactions (6.1)]. - patients being treated with teriflunomide [see drug interactions (7)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to leflunomide during pregnancy. health care providers and patients are encouraged to report pregnancies by calling 1-877-311-8972 or visit

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

burel pharmaceuticals, llc - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide tablets, usp are indicated for the treatment of adults with active rheumatoid arthritis (ra). leflunomide is contraindicated in: - pregnant women. leflunomide may cause fetal harm. if a woman becomes pregnant while taking this drug, stop leflunomide, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [see warnings and precautions (5.1 and 5.3) and use in specific populations (8.1)]. - patients with severe hepatic impairment [see warnings and precautions (5.2)]. - patients with known hypersensitivity to leflunomide or any of the other components of leflunomide. known reactions include anaphylaxis [see adverse reactions (6.1)]. - patients being treated with teriflunomide [see drug interactions (7)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to leflunomide during pregnancy. health care providers and patients are encouraged to report pregnancies by calling 1-877-311-8972 or visit

フランス - フランス語 - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

biogaran - léflunomide 10 mg - comprimé - pour un comprimé > léflunomide 10 mg - les indications thérapeutiques ne sont pas disponibles.

フランス - フランス語 - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

biogaran - léflunomide 20 mg - comprimé - pour un comprimé > léflunomide 20 mg - les indications thérapeutiques ne sont pas disponibles.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - leflunomide, quantity: 20 mg - tablet, uncoated - excipient ingredients: crospovidone; magnesium stearate; colloidal anhydrous silica; lactose - leflunomide apotex is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. genrx leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of genrx leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - leflunomide, quantity: 10 mg - tablet, uncoated - excipient ingredients: lactose; crospovidone; colloidal anhydrous silica; magnesium stearate - leflunomide apotex is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. genrx leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of genrx leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).